Goldmoney Inc. Announces Normal Course Issuer Bid
March 05, 2018 07:30 ET
|
Goldmoney Inc.
TORONTO, March 05, 2018 (GLOBE NEWSWIRE) -- Goldmoney Inc. (TSX:XAU) (“Goldmoney” or the “Company”) announces acceptance by the Toronto Stock Exchange (the "TSX") of Goldmoney’s Notice of Intention...
Lightbridge Schedules 2017 Year End Earnings and Business Update Conference Call
March 05, 2018 07:30 ET
|
Lightbridge Corporation
RESTON, Va., March 05, 2018 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:LTBR), a nuclear fuel technology development company, today announced that it will host a conference call on Friday,...
McDermott Awarded Detailed Engineering and Long Lead Procurement for the BP Cassia C Compression Platform
March 05, 2018 07:30 ET
|
McDermott International, Inc.
McDermott to build on its strong collaborative relationship with BP on the Cassia C Compression Platform in Trinidad and TobagoThis award builds on McDermott’s work on the BP Trinidad & Tobago,...
Euroseas Ltd. Reports Results for the Year and Quarter Ended December 31, 2017
March 05, 2018 07:30 ET
|
Euroseas
MAROUSSI, ATHENS, Greece, March 05, 2018 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ:ESEA) (the “Company” or “Euroseas”), an owner and operator of drybulk and container carrier vessels and provider of...
Factors of Influence in 2018, Key Indicators and Opportunity within Arch Coal, Norfolk Souther, Public Storage, VirnetX Holding, Xcel Energy, and Investors Real Estate Trust — New Research Emphasizes Economic Growth
March 05, 2018 07:30 ET
|
Fundamental Markets
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2018
March 05, 2018 07:30 ET
|
Amicus Therapeutics, Inc.
CRANBURY, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced upcoming presentations at two investor conferences in March. John F. Crowley, Chairman and Chief...
Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting
March 05, 2018 07:30 ET
|
Strongbridge Biopharma plc
~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Improvements in Short-Term Attack Rates as Adults ~ ~ Pooled Analysis of Two Phase 3...
Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston
March 05, 2018 07:20 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release - No. 06 / 2018Zealand...
Worldwide Small Cells Market Shares, Strategies, and Forecasts, 2018-2024
March 05, 2018 07:19 ET
|
Research and Markets
Dublin, March 05, 2018 (GLOBE NEWSWIRE) -- The "Small Cells: Market Shares, Strategies, and Forecasts, Worldwide 2018-2024" report from Wintergreen Research, Inc has been added to ...
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Ubiquiti Networks, Inc. Shareholders
March 05, 2018 07:18 ET
|
Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Ubiquiti Networks, Inc. (Nasdaq:UBNT) (“Ubiquiti” or the “Company”) shareholders that a...
- September 19, 2024 10:05 ET aequum Leadership Participates at SIIA National Conference 2024: Presents Claims Pricing Solutions for Plan Sponsors and Participants
- September 19, 2024 10:04 ET DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Arbor